Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03EDR
|
|||
| Former ID |
DNC002805
|
|||
| Drug Name |
N-Acetyl-N'-Beta-D-Glucopyranosyl Urea
|
|||
| Synonyms |
N-ACETYL-N'-BETA-D-GLUCOPYRANOSYL UREA; CHEMBL443455; 1kti; DB03218; AC1L9K3W; SCHEMBL4307948; BDBM50263770; N-Acetyl-N'-(beta-D-glucopyranosyl)urea; N-(acetylcarbamoyl)-beta-D-glucopyranosylamine; N-ACETYL-N''-BETA-D-GLUCOPYRANOSYL UREA; N-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]carbamoyl]acetamide; N-((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-ylcarbamoyl)acetamide
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C9H16N2O7
|
|||
| Canonical SMILES |
CC(=O)NC(=O)NC1C(C(C(C(O1)CO)O)O)O
|
|||
| InChI |
1S/C9H16N2O7/c1-3(13)10-9(17)11-8-7(16)6(15)5(14)4(2-12)18-8/h4-8,12,14-16H,2H2,1H3,(H2,10,11,13,17)/t4-,5-,6+,7-,8-/m1/s1
|
|||
| InChIKey |
UQKBNLXZEGBQAF-JAJWTYFOSA-N
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Glycogen phosphorylase muscle form (GP) | Target Info | Inhibitor | [1] |
| BioCyc | Glycogenolysis | |||
| KEGG Pathway | Starch and sucrose metabolism | |||
| Metabolic pathways | ||||
| Insulin signaling pathway | ||||
| Glucagon signaling pathway | ||||
| Panther Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||
| WikiPathways | Glycogen Metabolism | |||
| Metabolism of carbohydrates | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 2011 Jan;39(Database issue):D1035-41. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.